Introduction
============

Repeated embryo implantation failure is a form of refractory infertility with unknown etiology ([@b1-etm-0-0-5114]). It is generally believed that repeated implantation failure is closely related to embryo quality and abnormal endometrial receptivity ([@b2-etm-0-0-5114]). *In vitro* fertilization-embryo transfer is the main method for the treatment of infertility. Although some progress has been achieved in clinical practice, some patients still experience repeated implantation failure ([@b3-etm-0-0-5114]). The key to the success of *in vitro* fertilization-embryo transfer is endometrial receptivity. Factors affecting endometrial receptivity include endometrial thickness, blood supply and other factors ([@b4-etm-0-0-5114]--[@b6-etm-0-0-5114]). Vaginal color Doppler ultrasonography is a non-invasive and easy to operate imaging method with great clinical application in the detection of endometrial receptivity that has attracted more attention lately ([@b7-etm-0-0-5114]--[@b9-etm-0-0-5114]). However, the blood flow parameters used in the evaluation of endometrial receptivity by vaginal color Doppler ultrasonography have not been determined ([@b10-etm-0-0-5114]). This study aimed to investigate the features of uterine artery blood flow by vaginal color Doppler ultrasonography in patients with repeated embryo implantation failure, and to explore the correlation between uterine artery blood flow parameters and microvessel density (MVD) to develop a feasible diagnostic method to predict the outcomes of embryo transfer.

Patients and methods
====================

### Patient information

We recruited 80 patients who underwent *in vitro* fertilization and embryo transfer therapy in the Third Affiliated Hospital of Zhengzhou University (Henan, China) from September 2014 to January 2016. The ages ranged from 23 to 38 years with a mean age of 32.6±1.7 years. The number of basal sinus follicles was 6--10 and the average number of basal ganglia was 8.46±1.65. Inclusion criteria: i) The causes of infertility were tubal factors or factors from their male partner, all the patients received *in vitro* fertilization-embryo transfer, and their age was below 40 years; ii) basal follicle stimulating hormone (bFSH) levels \<10 mIU/ml; iii) more than 8 eggs were obtained per *in vitro* fertilization-embryo transfer treatment cycle and more than 5 could be implanted; and iv) all the patients or their family members signed the informed consent. Exclusion criteria: i) Hydrosalpinx; ii) endometrial damage; iii) chromosomal abnormalities; iv) endocrine abnormalities; and v) combined with thyroid disease and other autoimmune diseases. A follow-up study was performed on the outcomes of the 80 patients subjected to *in vitro* fertilization and embryo transfer. We divided the patients into the pregnancy group (successful pregnancy, n=50) or repeated implantation failure group (more than 2 failures of *in vitro* fertilization-embryo transfer, n=30). The study was approved by the Ethics Committee of the Third Affiliated Hospital of Zhengzhou University (Henan, China).

### Vaginal color Doppler ultrasonography

The same color ultrasound instrument (Fukuda Denshi Co., Ltd., Tokyo, Japan) was used for this study and all the procedures were performed by the same ultrasound physician. The vaginal ultrasound probe (8 MHz) was used in all the subjects. Patients received human chorionic gonadotropin (HCG). We detected the following endometrium blood parameters by ultrasound: Endometrial thickness, peak systolic velocity/end diastolic velocity (S/D), pulsatility index (PI) and resistance index (RI).

### SP method to detect F8 factor-labeled microvessels

On day 10 of the menstrual cycle, the test was carried out by using the urine testosterone (LH) test paper. On day 8 after the urine LH peak, the uterine endometrial tissue was scraped and collected using a curette (no. 5) after PI test. The endometrial tissue was fixed in 10% formaldehyde solution and embedded in paraffin. The endometrial tissue specimens were then subjected to the SP method. Primary rabbit anti-human F8 factor polyclonal antibody and anti-rabbit secondary antibody were both purchased from Shanghai Qunji Biotech Co., Ltd. (Shanghai, China). All procedures were performed according to the manufacturer\'s instructions. Primary antibody was replaced with phosphate-buffered saline (PBS) to serve as a negative control, and F8 factor-positive tissue was used as a positive control.

### Indicator observation and the result determination

i\) The endometrial thickness and uterine artery blood flow para-meters (S/D, PI and RI) were measured. ii) MVD counting: The vascular endothelial cell marker F8 factor-associated antigen was stained in specimens. Tissue sections were observed under the microscope and the mean number of MVDs of 5 visual fields were recorded. The stained endothelial cells were counted according to 1 MVD ([@b11-etm-0-0-5114]). iii) Investigation of the correlation between uterine artery blood flow parameters (S/D, PI and RI) and MVD in the repeated implantation failure group.

### Statistical analysis

Statistical analysis was performed using SPSS 20.0 statistical software (IBM SPSS, Armonk, NY, USA). The measurement data were expressed as mean ± standard deviation (mean ± SD) and analyzed by t-test. The measurement data were analyzed by χ^2^ test. The correlation analysis was performed using Spearman correlation analysis. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Endometrial thickness and uterine artery blood flow

We first examined the endometrial thickness and uterine blood flow in the pregnancy and repeated implantation failure groups. As shown in [Table I](#tI-etm-0-0-5114){ref-type="table"}, we found no significant differences in the thickness of endometrium (HCG endometrial thickness) and uterine artery blood flow parameters (S/D and PI) between the two groups (p\>0.05). The RI value of endometrial blood flow in the repeated implantation failure group was significantly higher than that in the pregnancy group (p\<0.05).

### Endometrial MVD

The MVD in the repeated implantation failure group was 3.46±0.84, which was significantly lower than that the 5.52±1.03 of the pregnancy group (t=9.027, p\<0.05) ([Fig. 1](#f1-etm-0-0-5114){ref-type="fig"}). Immunohistochemistry of vascular endothelial cell marker F8 factor showed that MVD was significantly higher in the pregnancy group than that in repeated implantation failure group.

### Correlation between uterine artery blood flow parameters and MVD

Spearman correlation analysis showed that the S/D value of uterine artery blood flow in the repeated implantation failure group was not correlated with MVD (r=0.082, p\>0.05) or uterine artery blood flow PI (r=0.176, p\>0.05), but was positively correlated with RI (r=0.515, p\<0.05) ([Table II](#tII-etm-0-0-5114){ref-type="table"}).

Discussion
==========

The clinical application of *in vitro* fertilization-embryo transfer technology has attracted recent attention. Although this treatment increases the rate of pregnancy, the successful rate of single embryo implantation is still unsatisfactory ([@b12-etm-0-0-5114]). Around 30% of embryos are successfully implanted under natural conception conditions, but the success rate of individual embryos during *in vitro* fertilization and embryo transfer is only 10--15% ([@b13-etm-0-0-5114],[@b14-etm-0-0-5114]). Factors affecting the effectiveness of *in vitro* fertilization and embryo transfer therapy are endometrial receptivity and embryonic factors.

Studies have shown that vaginal color Doppler ultrasound can predict and evaluate endometrial receptivity through the thickness and shape of the endometrium ([@b15-etm-0-0-5114]--[@b17-etm-0-0-5114]). Some scholars believe that endometrial blood flow is closely related with endometrial receptivity and is beneficial for embryo implantation and development ([@b18-etm-0-0-5114],[@b19-etm-0-0-5114]). Studies have confirmed that the higher MVD value usually leads to more abundant capillaries in newborns ([@b20-etm-0-0-5114]). Therefore, endometrial MVD during the implantation window can predict endometrial receptivity. F8 factor is an important vascular endothelium-specific marker that is often used as a marker for MVD ([@b21-etm-0-0-5114]). Our results show that endometrium MVD in the repeated implantation failure group was significantly lower than that of the MVD in the pregnancy group. Thus, endometrial angiogenesis is more robust in patients with successful pregnancy, which in turn promotes the formation of new blood vessels that benefit embryo implantation, and increase the success rate of pregnancy, which is consistent with previous studies ([@b22-etm-0-0-5114]).

Further analysis showed no significant differences in the endometrial thickness (HCG endometrial thickness) and uterine artery blood flow (S/D and PI) between the two groups. The RI value of endometrial blood flow in repeated implantation group was significantly higher than that in pregnancy group. Spearman correlation analysis showed that the S/D value of uterine artery blood flow in repeated implantation failure group was not correlated with MVD and uterine artery blood flow PI, but was positively correlated with RI. Thus, MVD in neonatal blood vessels can be assessed by detecting the endometrial blood flow RI values using color Doppler ultrasonography, which provides a simple method for clinical detection and determination of endometrial angiogenesis.

In conclusion, endometrium MVD in patients with repeated implantation failure during the implantation window was significantly lower than that in patients with successful *in vitro* fertilization and embryo transfer. We found a significant difference in uterine artery blood flow RI between the two groups. The uterine artery blood flow RI value in patients with repeated implantation failure was positively correlated with MVD, which has clinical significance in predicting the outcome of embryo transfer.
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###### 

Endometrial thickness and uterine artery blood flow parameters.

                                                     Left uterine artery blood flow   Right uterine artery blood flow                                   
  -------------------------------------- ----------- -------------------------------- --------------------------------- ----------- --------- --------- -----------
  Repeated implantation failure (n=30)   0.91±0.26   7.8±2.4                          2.4±0.4                           0.95±0.12   7.7±0.6   2.3±0.3   0.95±0.12
  Pregnancy (n=50)                       0.89±0.24   7.7±2.1                          2.3±0.3                           0.78±0.11   7.6±0.5   2.2±0.2   0.78±0.11
  t-test                                 0.124       1.043                            0.156                             8.336       0.137     0.842     8.336
  P-value                                \>0.05      \>0.05                           \>0.05                            \<0.05      \>0.05    \>0.05    \<0.05

HCG, human chorionic gonadotropin; PI, pulsatility index; RI, resistance index.

###### 

Correlation analysis of uterine artery blood flow parameters (S/D, PI and RI) and MVD.

  Indexes   r value   P-value
  --------- --------- ---------
  S/D       0.082     \>0.05
  PI        0.176     \>0.05
  RI        0.515     \<0.05

PI, pulsatility index; RI, resistance index; MVD, microvessel density.
